Novo Nordisk (spons. ADRs) Aktie

50,40 EUR -0,70 EUR -1,37 %

17:04:10

STU

58,84 USD -0,72 USD -1,21 %

17:04:19

BTT

Novo Nordisk (spons. ADRs) jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

KGV26,16Div. Rendite1,37%

WKN866931

ISINUS6701002056

SymbolNVO

Novo Nordisk (spons. ADRs) Aktien News

Sortieren:Datum Meistgelesen

27.02.25PR NewswireNovo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - NVO

24.02.25MotleyFoolWall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

21.02.25MotleyFoolWhy Novo Nordisk Stock Popped on Friday

21.02.25PR NewswireInvestors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO

20.02.25ZacksNovo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

19.02.25BenzingaSpotlight on Novo Nordisk: Analyzing the Surge in Options Activity

19.02.25Benzinga$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today

19.02.25BenzingaNovo Nordisk Sues Singapore-Based KBP Biosciences Over Alleged Data Misrepresentation In $1.3 Billion Hypertension Drug Deal, Seeks Damages

19.02.25Business TimesAll assets of biotech founder in Novo Nordisk suit frozen, including US$218 million in DBS account

19.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO

18.02.25PR NewswireLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Lawsuit - NVO

17.02.25PR NewswireNVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

14.02.25MotleyFoolNovo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon

13.02.25MotleyFoolWhy Novo Nordisk Stock Keeps Going Down

11.02.25MotleyFoolWhy Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

10.02.25ZacksIs It Worth Investing in Novo Nordisk (NVO) Based on Wall Street's Bullish Views?

08.02.25MotleyFoolIs Novo Nordisk Stock a Buy Now?

07.02.25PR NewswireNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

07.02.25BenzingaWhat the Options Market Tells Us About Novo Nordisk

07.02.25BenzingaNovo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data

06.02.25BenzingaNovo Nordisk Opposes 'Government Price Setting' As Elon Musk's DOGE Gains Access To CMS Amid Bernie Sanders' Criticism

05.02.25MotleyFoolWhy Novo Nordisk Stock Is Soaring Today

05.02.25New York TimesNovo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

05.02.25MotleyFoolNovo Nordisk (NVO) Q4 2024 Earnings Call Transcript

05.02.25BenzingaNovo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026

05.02.25MarketWatchNovo Nordisk sales beat estimates, but the story wasn’t Ozempic

05.02.25RTE.ieNovo Nordisk sees slower sales growth in 2025

05.02.25Financial TimesObesity drug sales surge at Novo Nordisk

04.02.25Benzinga$100 Invested In Novo Nordisk 5 Years Ago Would Be Worth This Much Today

04.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO

04.02.25BenzingaNovo Nordisk Stock Slides Before Q4 Earnings: Analysts Still See 68% Upside

04.02.25BenzingaNovo Nordisk Faces Investor Concerns Over Hybrid CagriSema Trial Results For Weight Loss

03.02.25BenzingaSpotlight on Novo Nordisk: Analyzing the Surge in Options Activity

03.02.25ZacksNovo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?

03.02.25PR NewswireMarch 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO

02.02.25MotleyFoolForget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands

31.01.25PR NewswireShareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

30.01.25PR NewswireNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

30.01.25PR NewswireNVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline

29.01.25ZacksWhy Novo Nordisk (NVO) Dipped More Than Broader Market Today

Novo Nordisk (spons. ADRs) News

Novo Nordisk (spons. ADRs) News: auf dieser Seite finden Sie alle Novo Nordisk (spons. ADRs) News und Nachrichten zur Novo Nordisk (spons. ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk (spons. ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk (spons. ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.